GDRX logo

GoodRx Holdings (GDRX) CAPEX

Annual CAPEX

$55.77 M
+$552.00 K+1.00%

December 31, 2023


Summary


Performance

GDRX CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGDRXcash flowmetrics:

Quarterly CAPEX

$15.86 M
-$1.37 M-7.95%

September 30, 2024


Summary


Performance

GDRX Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGDRXcash flowmetrics:

TTM CAPEX

$66.58 M
+$2.21 M+3.44%

September 30, 2024


Summary


Performance

GDRX TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGDRXcash flowmetrics:

GDRX CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+1.0%+16.2%+14.4%
3 y3 years+55.7%+16.2%+14.4%
5 y5 years+1512.7%+16.2%+14.4%

GDRX CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+61.8%-23.1%+71.3%at high+93.2%
5 y5-yearat high+870.0%-23.1%+365.5%at high+1854.1%
alltimeall timeat high+1512.7%-23.1%+365.5%at high+1854.1%

GoodRx Holdings CAPEX History

DateAnnualQuarterlyTTM
Sep 2024
-
$15.86 M(-8.0%)
$66.58 M(+3.4%)
Jun 2024
-
$17.23 M(-16.4%)
$64.36 M(+3.7%)
Mar 2024
-
$20.61 M(+60.2%)
$62.09 M(+11.3%)
Dec 2023
$55.77 M(+1.0%)
$12.87 M(-5.7%)
$55.77 M(-4.2%)
Sep 2023
-
$13.65 M(-8.8%)
$58.18 M(-0.2%)
Jun 2023
-
$14.96 M(+4.7%)
$58.31 M(+2.2%)
Mar 2023
-
$14.29 M(-6.6%)
$57.08 M(+3.4%)
Dec 2022
$55.21 M
$15.29 M(+11.0%)
$55.21 M(+12.3%)
Sep 2022
-
$13.78 M(+0.3%)
$49.18 M(+12.0%)
Jun 2022
-
$13.73 M(+10.6%)
$43.92 M(+18.1%)
DateAnnualQuarterlyTTM
Mar 2022
-
$12.42 M(+34.1%)
$37.18 M(+7.9%)
Dec 2021
$34.46 M(-3.8%)
$9.26 M(+8.8%)
$34.46 M(-1.6%)
Sep 2021
-
$8.51 M(+21.7%)
$35.01 M(-20.8%)
Jun 2021
-
$6.99 M(-27.9%)
$44.19 M(+4.9%)
Mar 2021
-
$9.70 M(-1.2%)
$42.11 M(+17.6%)
Dec 2020
$35.82 M(+523.1%)
$9.81 M(-44.6%)
$35.82 M(+37.7%)
Sep 2020
-
$17.70 M(+260.2%)
$26.01 M(+212.7%)
Jun 2020
-
$4.91 M(+44.2%)
$8.32 M(+144.2%)
Mar 2020
-
$3.41 M
$3.41 M
Dec 2019
$5.75 M(+66.3%)
-
-
Dec 2018
$3.46 M
-
-

FAQ

  • What is GoodRx Holdings annual capital expenditures?
  • What is the all time high annual CAPEX for GoodRx Holdings?
  • What is GoodRx Holdings annual CAPEX year-on-year change?
  • What is GoodRx Holdings quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for GoodRx Holdings?
  • What is GoodRx Holdings quarterly CAPEX year-on-year change?
  • What is GoodRx Holdings TTM capital expenditures?
  • What is the all time high TTM CAPEX for GoodRx Holdings?
  • What is GoodRx Holdings TTM CAPEX year-on-year change?

What is GoodRx Holdings annual capital expenditures?

The current annual CAPEX of GDRX is $55.77 M

What is the all time high annual CAPEX for GoodRx Holdings?

GoodRx Holdings all-time high annual capital expenditures is $55.77 M

What is GoodRx Holdings annual CAPEX year-on-year change?

Over the past year, GDRX annual capital expenditures has changed by +$552.00 K (+1.00%)

What is GoodRx Holdings quarterly capital expenditures?

The current quarterly CAPEX of GDRX is $15.86 M

What is the all time high quarterly CAPEX for GoodRx Holdings?

GoodRx Holdings all-time high quarterly capital expenditures is $20.61 M

What is GoodRx Holdings quarterly CAPEX year-on-year change?

Over the past year, GDRX quarterly capital expenditures has changed by +$2.21 M (+16.21%)

What is GoodRx Holdings TTM capital expenditures?

The current TTM CAPEX of GDRX is $66.58 M

What is the all time high TTM CAPEX for GoodRx Holdings?

GoodRx Holdings all-time high TTM capital expenditures is $66.58 M

What is GoodRx Holdings TTM CAPEX year-on-year change?

Over the past year, GDRX TTM capital expenditures has changed by +$8.39 M (+14.42%)